I-Mab Announces Upcoming Participation at September Conferences
- Written by PR Newswire
![]() |
ROCKVILLE, Md. and SHANGHAI, Sept. 5, 2023 /PRNewswire/ -- I-Mab (Nasdaq: IMAB) (the "Company"), is a global biotechnology company focused on bringing highly differentiated medicines to patients around the world through the discovery, development, and commercialization of novel immunotherapies and biologics for oncology, today announced its...
Read more: I-Mab Announces Upcoming Participation at September Conferences















